RxDoctor Payments Data

Cynthia Macdonald, NP

Adult Health · Charleston, SCNPI 1295988996

Payments from drug & device makers

$1,386in general payments, 2019–2025

Across 56 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scpharmaceuticals Inc.$391
  • Boehringer Ingelheim$245
  • AstraZeneca$195
  • Lexicon Pharmaceuticals, Inc.$171
  • Abbott$104
  • E.r. Squibb & Sons, L.L.C.$93
  • plus $188 from 5 others

What the payments were for

  • Food & beverage$1,386100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,386 in reported general payments places this provider in the 55th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$35,815
Medicare patients
253
Services billed
423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan54$59,648
JardianceEmpagliflozin52$47,625
EliquisApixaban37$36,814
FarxigaDapagliflozin Propanediol12$13,274
Bumetanide45$1,791
Potassium Chloride64$969
Spironolactone83$426
Carvedilol60$360
Metoprolol Succinate45$348
Furosemide81$297
Atorvastatin Calcium50$248
Hydralazine Hcl35$197
Amlodipine Besylate21$120
Gabapentin14$101
Losartan Potassium21$98

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$245$47,62552 claims
AstraZenecaFarxiga$195$13,27412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 292 adult health providers in South Carolina.

Other adult health in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →